Therapeutics News and Research

RSS

Intratumoral bacteria linked with natural purple photosynthetic bacteria show strong anticancer efficacy

Cancer remains one of the leading causes of death worldwide. Researchers are constantly looking for new therapies with improved anticancer activity, fewer side effects, and lower costs.

8 May 2023

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

Researchers highlighted the pace of development of COVID-19 therapies during the pandemic and the challenges that hinder the widespread availability of anticoronavirals.

8 May 2023

New technology allows to study how a single protein behaves and changes over time

Scientists have developed new technology which has made it possible to isolate and study how a single protein – 10,000 times thinner than a human hair – behaves and changes over time.

8 May 2023

UCF microbiologist uncovers the evolutionary origins of antimicrobial resistance in bacteria

Bacteria naturally adapt to various environmental stimuli and as they mutate, these changes can make them resistant to drugs that would kill or slow their growth.

5 May 2023

Cancer stem cell test can lead to increased survival for patients with glioblastoma

New multi-institutional phase 3 clinical trial data published May 2 in Cell Reports Medicine found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.

5 May 2023

Evaluating the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines

Researchers evaluated the effectiveness, in absolute and relative terms, of vaccines.

5 May 2023

Exploring the World of RNA Chemistry

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Philip Bevilacqua from Pennsylvania State University about the world of RNA chemistry.

From Pittcon 5 May 2023

Researchers identify a potential safer route to pain relief

Strategies to treat pain without triggering dangerous side effects such as euphoria and addiction have proven elusive.

4 May 2023

Study pinpoints how gut microbes boost the body's response to cancer immunotherapy

Cancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patients get the same benefit from these powerful therapies.

4 May 2023

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today announced the introduction of Gyrolab® Generic Cyno Anti-Drug Antibodies (ADA) Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.

From Gyros Protein Technologies AB 4 May 2023

Researchers report positive results from Phase 2 clinical trial of investigational treatment against long COVID fatigue

Researchers from the University of Oxford have reported findings from a Phase 2 clinical trial investigating the efficacy of an investigational treatment against long COVID fatigue.

3 May 2023

Boxing could improve quality of life for Parkinson's patients

When we think of boxing, it's understandable many of us wouldn't associate it with being 'good' for our brains.

3 May 2023

New technology can deliver gene therapy directly to the lung

Scientists at UMass Chan Medical School have developed a technology to deliver gene therapy directly to lung tissue through intranasal administration, a development that could potentially create a new class of treatments for lung disease.

2 May 2023

African psychedelic plant medicine inspires new drug candidates for treating addiction and depression

Scientists have developed two new drug candidates for potentially treating addiction and depression, modeled on the pharmacology of a traditional African psychedelic plant medicine called ibogaine.

2 May 2023

Paving the Way for New Drugs through Particle Perfection

Do particles hold the power to pave the way for new drugs? In this interview, we speak to Ben Knappett, head of science and applications at Particle Works to find out more!

From Society for Laboratory Automation and Screening (SLAS) 2 May 2023

Inhibiting mitochondrial regulator ATAD3A could prevent head and neck cancer development

A new research perspective was published in Oncoscience (Volume 10) on April 4, 2023, entitled, "Mitochondrial regulator ATAD3A: a molecular determinant favoring head and neck cancer development."

28 Apr 2023

New approach for efficient engineering of cell and gene therapies

A new approach to the genetic engineering of cells promises significant improvements in speed, efficiency, and reduction in cellular toxicity compared to current methods.

28 Apr 2023

Researchers identify the likely reason for heart damage from cancer drugs

Safer cancer drugs are now one step closer after a new study led by UCL (University College London) researchers found the likely reason that some treatments damage the heart.

28 Apr 2023

New strategy for identifying small molecules offers a promising path for discovering targeted drugs

Scripps Research scientists have developed a new strategy for identifying small molecules that can change the function of proteins, offering a promising path for discovering targeted drugs.

27 Apr 2023

Testing hundreds of existing therapeutics to fight blood cancer more effectively

Multiple myeloma is a rare blood cancer caused by the uncontrolled multiplication of abnormal plasma cells.

27 Apr 2023

Therapeutics News and Research

Intratumoral bacteria linked with natural purple photosynthetic bacteria show strong anticancer efficacy

Anticoronavirals: the development of COVID-19 therapies and the challenges that remain

New technology allows to study how a single protein behaves and changes over time

UCF microbiologist uncovers the evolutionary origins of antimicrobial resistance in bacteria

Cancer stem cell test can lead to increased survival for patients with glioblastoma

Evaluating the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines

Exploring the World of RNA Chemistry

Researchers identify a potential safer route to pain relief

Study pinpoints how gut microbes boost the body's response to cancer immunotherapy

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

Researchers report positive results from Phase 2 clinical trial of investigational treatment against long COVID fatigue

Boxing could improve quality of life for Parkinson's patients

New technology can deliver gene therapy directly to the lung

African psychedelic plant medicine inspires new drug candidates for treating addiction and depression

Paving the Way for New Drugs through Particle Perfection

Inhibiting mitochondrial regulator ATAD3A could prevent head and neck cancer development

New approach for efficient engineering of cell and gene therapies

Researchers identify the likely reason for heart damage from cancer drugs

New strategy for identifying small molecules offers a promising path for discovering targeted drugs

Testing hundreds of existing therapeutics to fight blood cancer more effectively

Industry Focus eBook - Microbiome (1st edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News